date,title,source
Oct-17-18,Stocks Jump 2%+ on Solid Earnings,Zacks
Oct-19-18,Phase 2 GEOMETRY mono-1 Trial of Investigational Medicine Capmatinib Shows Positive Results in Patients with MET-mutated Advanced NSCLC,Business Wire
Oct-24-18,Incyte (INCY) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-24-18,"Biotech Stock Roundup: BIIB Tops, MACK Plunges, REGN's Asthma Drug Gets FDA Nod",Zacks
Oct-25-18,Incyte Named a 2018 Top Employer by Science Magazine,Business Wire
Oct-30-18,Incyte Corp (INCY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-30-18,"Incyte (INCY) Misses on Q3 Earnings & Revenues, Updates View",Zacks
Oct-30-18,Edited Transcript of INCY earnings conference call or presentation 30-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-30-18,Incyte (INCY) Misses Q3 Earnings and Revenue Estimates,Zacks
Oct-30-18,Incyte: 3Q Earnings Snapshot,Associated Press
Oct-30-18,Incyte Reports 2018 Third Quarter and Nine Month Financial Results and Provides Updates on Key Clinical Programs,Business Wire
Oct-31-18,Edited Transcript of INCY earnings conference call or presentation 30-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,"Scary Markets, Frightening Stocks, and How to Keep From Panicking",Motley Fool
Nov-01-18,Edited Transcript of INCY earnings conference call or presentation 30-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Multiple Abstracts Highlighting Data from Incytes Targeted Therapy Portfolio Accepted for Presentation at the 60th Annual ASH Meeting,Business Wire
Nov-01-18,"3 Big Stock Charts for Thursday: Walmart, Prologis and Incyte",InvestorPlace
Nov-01-18,Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Incyte,ACCESSWIRE
